BUPROPION- bupropion hydrochloride tablet, extended release Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

bupropion- bupropion hydrochloride tablet, extended release

remedyrepack inc. - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride extended-release (sr) tablets are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies (14)] . the efficacy of bupropion hydrochloride extended-release (sr) tablets in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see clinical studies (14)] . - bupropion hydrochloride extended-release (sr) tablets are contraindicated in patients with a seizure disorder. - bupropion hydrochloride extended-release (sr) tablets are contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incid

LOSARTAN POTASSIUM- losartan potassium tablet, film coated Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

losartan potassium- losartan potassium tablet, film coated

lake erie medical dba quality care products llc - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 50 mg - losartan potassium tablets usp are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents, including diuretics. hypertensive patients with left ventricular hypertrophy losartan potassium tablets usp are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race and clinical pharmacology, pharmacodynamics and clinical effects, reduction in the risk of stroke, race.) losartan potassium tablets usp are indicated for the treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria (urinary albumin to creatinine ratio ≥300 mg/g) in patients with type 2 diabetes and a history of hypertension. in this population, losartan potassium tablets usp are reduce the rate of progression of nephropathy as measured by the occurrence of doubling of serum creatinine or end stage renal disease (need for di

BENAZEPRIL HYDROCHLORIDE tablet, coated Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

benazepril hydrochloride tablet, coated

remedyrepack inc. - benazepril hydrochloride (unii: n1sn99t69t) (benazeprilat - unii:jrm708l703) - benazepril hydrochloride tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from

Intravenous administration set, buret Australija - anglų - Department of Health (Therapeutic Goods Administration)

intravenous administration set, buret

icu medical australia pty ltd - 12159 - intravenous administration set, buret - [12159 - intravenous administration set, burette] an administration set, containing a calibrated burette for fluid volume measurement, used to deliver accurately measured volumes of intravenous (iv) solutions to the infusion site. it may have a variety of connections, clamps, lengths, and injection ports. it is used for gravitational intravenous administration. this is a sterile, single-use device.

Intravenous administration set, buret Australija - anglų - Department of Health (Therapeutic Goods Administration)

intravenous administration set, buret

icu medical australia pty ltd - 12159 - intravenous administration set, buret - an administration set, containing a calibrated burette for fluid volume measurement, used to deliver accurately measured volumes of intravenous solutions to the infusion site. it may have a variety of connections, clamps, lengths, and injection ports. it is typically used for gravitational intravenous administration or with an infusion pump. this is a sterile, single-use device.

PAROXETINE- paroxetine hydrochloride tablet, film coated Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

paroxetine- paroxetine hydrochloride tablet, film coated

nucare pharmaceuticals, inc. - paroxetine hydrochloride anhydrous (unii: 3i3t11ud2s) (paroxetine - unii:41vrh5220h) - paroxetine 20 mg - major depressive disorder: paroxetine tablets are indicated for the treatment of major depressive disorder. the efficacy of paroxetine tablets in the treatment of a major depressive episode was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical pharmacology: clinical trials ). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paroxetine tablets in hospitalized depressed patients have not been adequa

Speculum, vaginal, single use Australija - anglų - Department of Health (Therapeutic Goods Administration)

speculum, vaginal, single use

wishmed pty ltd - 37468 - speculum, vaginal, single use - vaginal speculum is used during examination and treatment of the vagina to provide access to the interior, usually by expanding/distending the opening to this orifice. this device may be designed with adjustable or fixed blades and may have built-in lighting. the device is made of plastic and is single-use and sterile.

Surgical procedure kit, general-purpose, single-use, non-medicated Australija - anglų - Department of Health (Therapeutic Goods Administration)

surgical procedure kit, general-purpose, single-use, non-medicated

wishmed pty ltd - 33961 - surgical procedure kit, general-purpose, single-use, non-medicated - the basic surgical procedure pack is a pre-packaged kit containing a tray, gauzes, cotton balls, paper towel and plastic forceps.

Applicator, absorbent tipped, sterile Australija - anglų - Department of Health (Therapeutic Goods Administration)

applicator, absorbent tipped, sterile

ntz group pty ltd - 33722 - applicator, absorbent tipped, sterile - swabs for the collection and transport of clinical samples for diagnostic testing: pcr, molecular assays etc

Closed-ended adhesive infant/paediatric urine collection bag Australija - anglų - Department of Health (Therapeutic Goods Administration)

closed-ended adhesive infant/paediatric urine collection bag

wishmed pty ltd - 58930 - closed-ended adhesive infant/paediatric urine collection bag - a small plastic adhesive bag used for collecting the urine for specimen analysis.